Clinical Significance of Arginine Signaling in Patients with Cervical Cancer Receiving Cisplatin Chemoradiation Therapy

被引：0
|
作者：
Chen, H. H. W. [1 ]
Lee, W. Y. [2 ]
Lai, Y. H. [1 ]
机构：
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Radiat Oncol, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3106
引用
收藏
页码：E506 / E506
页数：1
相关论文
共 50 条
  • [41] Diffusion-weighted MRI and FDG PET/CT as Predictors of Tumor Treatment Response in Patients With Cervical Cancer Receiving Chemoradiation Therapy
    Wang, C.
    Hong, J.
    Lai, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S688 - S688
  • [42] Nephrotoxicity Evidence in patients receiving cisplatin therapy
    Duffy, Elizabeth A.
    Fitzgerald, Wendy
    Boyle, Kelley
    Rohatgi, Radha
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2018, 22 (02) : 175 - 183
  • [43] PHARMACOKINETICS OF ONDANSETRON IN PATIENTS RECEIVING CISPLATIN THERAPY
    PARR, MD
    MCINTYRE, WJ
    HENDERSON, LM
    MACDONALD, JS
    CHANDLER, MHH
    CLINICAL PHARMACY, 1992, 11 (12): : 1026 - 1029
  • [44] Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer
    Jiang, D. M.
    Raissouni, S.
    Mercer, J.
    Kumar, A.
    Goodwin, R.
    Heng, D. Y.
    Tang, P. A.
    Doll, C.
    MacLean, A.
    Powell, E.
    Price-Hiller, J.
    Monzon, J.
    Cheung, W. Y.
    Vickers, M. M.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2102 - 2106
  • [45] Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer
    Jiang, Maria
    Raissouni, Soundouss
    Mercer, Jamison
    Kumar, Aalok
    Goodwin, Rachel Anne
    Heng, Daniel Yick Chin
    Tang, Patricia A.
    Doll, Corinne M.
    MacLean, Anthony
    Powell, Erin Diana
    Hiller, Julie A. Price
    Monzon, Jose Gerard
    Vickers, Michael M.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
    Hagerstrom, Erik
    Lindberg, Lotte
    Bentzen, Jens
    Brodbaek, Kasper
    Zerahn, Bo
    Kristensen, Bent
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
  • [47] Anti-emetic therapy for cancer patients receiving chemotherapy including cisplatin
    Tsukuda, M
    SYDNEY '97 - XVI WORLD CONGRESS OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY, TOMES 1 AND 2, 1996, : 359 - 362
  • [48] Clinical Efficacy of Alternating Chemoradiation Therapy With Moderate-dose Brachytherapy for High-Risk Patients of Cervical Cancer
    Hirata, K.
    Kodaira, T.
    Tachibana, H.
    Tomita, N.
    Ito, J.
    Oshima, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S426 - S427
  • [49] Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer Reply
    Suntharalingam, Mohan
    Winter, Kathryn
    Ilson, David
    JAMA ONCOLOGY, 2018, 4 (06) : 888 - 889
  • [50] Retinoids enhance cisplatin-based chemoradiation in cervical cancer cells in vitro
    Scribner, DR
    Benbrook, DM
    GYNECOLOGIC ONCOLOGY, 2002, 85 (01) : 223 - 225
12345